Comparative Efficacy of Exosurf and Survanta Surfactants on Early Clinical Course of Respiratory Distress Syndrome and Complications of Prematurity

Journal of Perinatology

Volumn 17, Issue 6, 1997, Pages 455-460

  Modanlou, Houchang D ^a,d   Beharry, Kay ^b   Padilla, Guadalupe ^b   Norris, Karol ^b   Safvati, Shahriar ^b   Aranda, Jacob V ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; BIOLOGICAL PRODUCT; DIPALMITOYLPHOSPHATIDYLCHOLINE; FATTY ALCOHOL; LUNG SURFACTANT; MACROGOL DERIVATIVE; PHOSPHORYLCHOLINE;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD; BLOOD GAS ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG COMBINATION; FOLLOW UP; GESTATIONAL AGE; HUMAN; INCIDENCE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

BIOLOGICAL PRODUCTS; BLOOD GAS ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FATTY ALCOHOLS; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031264278     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Merritt TA, Hallman M, Bloom BT, et al. Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 1986;315:785-90.
2. Phibbs RH, Ballard RA, Clements JA, et al. Initial clinical trial of Exosurf, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics 1991;88:1-9.
3. Hoekstra RE, Jackson JC, Myers TF, et al. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 1991;88:10-8.
4. Long W, Thompson T, Sundell H, et al. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. J Pediatr 1991;118:595-605.
5. Horbar JD, Soll RF, Sutherland JM, et al. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med 1989;320:959-65.
6. Ernhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 1985;76:145-53.
7. Long W, Corbet A, Cotton R, et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. N Engl J Med 1991;325:1696-703.
8. Soil RF, Hoekstra RE, Fangman JJ, et al. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Pediatrics 1991;85:1092-102.
9. Bose C, Corbet A, Bose G, et al. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant. J Pediatr 1991;117:947-53.
10. Berry DD, Pramanik AK, Phillips JB, et al. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing ≥ 1250 grams with respiratory distress syndrome. J Pediatr 1994;124:294-301.
11. Corbet A, Bucciarelli R, Goldman S, et al. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. J Pediatr 1991;118: 277-84.
12. Horbar JD, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993;123:757-66.
13. An International classification of retinopathy of prematurity. Pediatrics 1984;74:127-33.
14. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Waslman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991;119:417-23.
15. Hallman M, Merritt TA, Jarvenpaa AL, et al. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr 1985;106:963-9.
16. Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 1988;82:683-91.
17. Survanta Multidose Study Group. Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant. J Pediatr 1994;124:962-7.
18. Pappin A, Shenker N, Hack M, Redline RW. Extensive intraalveolar pulmonary hemorrhage in infants dying after surfactant treatment. J Pediatr 1994;124:624-6.
19. McCord FB, Curstedt T, Halliday HL, McClure G, McC Reid M, Robertson B. Surfactant treatment and incidence of intraventricular hemorrhage in severe respiratory distress syndrome. Arch Dis Child 199;63:10-6.
20. Ferrara TB, Hoekstra RE, Couser RJ, et al. Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy. J Pediatr 1994;124:119-24.